Evoke Pharma (EVOK) Tops Q3 EPS by 11c

Evoke Pharma (NASDAQ: EVOK) reported Q3 EPS of ($0.51), $0.11 better than the analyst estimate of ($0.62). Revenue for the quarter came in at $1.56 million versus the consensus estimate of $1.26 million.

For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Credo Technology pops 3.5% as Evercore initiates with monster $325 price target
• FedEx (FDX) PT Lowered to $424 at Bernstein SocGen Group